Form 4 for DRMA Dermata Therapeutics, Inc.
Accepted 2021-11-26 00:00:00 ET · period of report 2021-11-23 · accession 0000905718-21-001541 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-11-26 | 2021-11-23 | DRMA | PROEHL GERALD T | Pres, CEO, COB, Dir, 10% | P - Purchase | $2.40 | +20.0K | 59.5K | +51% | +$48.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-23 | P | A | 20,000 | $2.40 | 59,512 | D | — | — |